Nair Vinay’s Elevance Health ELV Stock Holding History

Nair Vinay’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,814	Closed	-$280K	–	213
2015 Q1	$280K	Buy	+1,814	New	+$258K	0.2%	212

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Nair Vinay's ELV Position: Q2 2015 in Review

Nair Vinay sold out of Elevance Health (ELV) in Q2 2015, closing a stake of 1,814 shares — an estimated $280K sold.

Nair Vinay first reported a position in ELV in Q1 2015 and held it in 1 quarter. The position peaked at $280K in Q1 2015. 781 funds tracked by Wall St. Rank hold ELV as of Q2 2015.

Nair Vinay reported no remaining Elevance Health position as of Q2 2015 after selling out during the quarter.
Nair Vinay sold 1,814 Elevance Health shares in Q2 2015, an estimated $280K.
Nair Vinay first reported a position in Elevance Health in Q1 2015 and held it in 1 quarter.
Nair Vinay's Elevance Health position peaked at $280K in Q1 2015.
781 funds tracked by Wall St. Rank held Elevance Health as of Q2 2015.

Based on Nair Vinay's 13F filing for Q2 2015, filed 12 Aug 2015.